Copyright
©The Author(s) 2015.
World J Gastroenterol. Mar 14, 2015; 21(10): 2988-2996
Published online Mar 14, 2015. doi: 10.3748/wjg.v21.i10.2988
Published online Mar 14, 2015. doi: 10.3748/wjg.v21.i10.2988
Characteristics | |
Sex | |
Male | 45 (64.3 ) |
Female | 25 (35.7 ) |
Median age | 57 (13-81) |
Final diagnosis | |
Malignancy | 50 (71.4) |
Duct adenocarcinoma | 37 |
Cystadenocarcinoma | 4 |
Adenosquamous Carcinoma | 3 |
Metastatic tumor | 1 |
Lymphoma | 2 |
Neuroendocrine carcinoma | 3 |
Benign | 20 (28.6) |
Chronic pancreatitis | 8 |
Tubercle | 1 |
Autoimmune pancreatitis | 2 |
Cystadenoma/IPMN | 7 |
Neuroendocrine neoplasm | 2 |
SEN | SPE | PPV | NPV | ACC | Kappa | |
CECT | 82.0% | 65.0% | 85.4% | 59.1% | 77.1% | 0.456 |
PET/CT | 92.0% | 65.0% | 86.8% | 76.5% | 84.2% | 0.597 |
PET/CECT | 96.0% | 90.0% | 96.0% | 90.0% | 94.3% | 0.860 |
PET/CT vs CECT | χ2 = 2.210 | χ2 = 0.000 | χ2 = 0.04 | χ2 = 1.303 | χ2 = 1.147 | |
P = 0.137 | P = 1.000 | P = 1.303 | P = 0.254 | P = 0.284 | ||
PET/CECT vs PET/CT | χ2 = 0.709 | χ2 = 3.584 | χ2 = 2.735 | χ2 = 1.238 | χ2 = 3.659 | |
P = 0.400 | P = 0.058 | P = 0.098 | P = 0.266 | P = 0.056 | ||
PET/CECT vs CECT | χ2 = 5.005 | χ2 = 3.584 | χ2 = 3.289 | χ2 = 5.177 | χ2 = 8.400 | |
P = 0.025 | P = 0.580 | P = 0.070 | P = 0.023* | P = 0.004 |
Peripancreatic vessel invasion | Regional lymph node metastasis | Distant metastasis | |||||||||||||
SEN | SPE | PPV | NPV | ACC | SEN | SPE | PPV | NPV | ACC | SEN | SPE | PPV | NPV | ACC | |
CECT | 14 (93.3) | 15 (93.8) | 14 (93.3) | 15 (93.8) | 29 (93.5) | 12 (63.2) | 11 (91.7) | 12 (92.3) | 11 (61.1) | 23 (74.2) | 10 (58.8) | 33 (100) | 10 (100) | 33 (82.5) | 43 (86.0) |
Routine PET/CT | 4 (26.7) | 12 (75.0) | 4 (50) | 12 (52.2) | 16 (51.6) | 15 (78.9) | 10 (83.3) | 15 (88.2) | 10 (71.4) | 25 (80.6) | 14 (82.4) | 30 (90.9) | 14 (82.4) | 30 (90.9) | 44 (88) |
PET/CECT | 14 (93.3) | 15 (93.8) | 14 (93.3) | 15 (93.8) | 29 (93.5) | 17 (89.5) | 11 (91.7) | 17 (94.4) | 11 (84.6) | 28 (90.3) | 16 (94.1) | 32 (97.0) | 16 (94.1) | 32 (97.0) | 48 (96.0) |
PET/CECT vs PET/CT | χ2 = 13.889 P = 0.001 | χ2 = 2.133 P = 0.144 | χ2 = 5.759 P = 0.016 | χ2 = 7.657 P = 0.006 | χ2 = 13.697 P = 0.001 | χ2 = 0.792 P = 0.374 | χ2 = 0.381 P = 0.537 | χ2 = 0.430 P = 0.512 | χ2 = 0.678 P = 0.410 | χ2 = 1.170 P = 0.279 | χ2 = 1.133 P = 0.287 | χ2 = 1.065 P = 0.302 | χ2 = 1.133 P = 0.287 | χ2 = 1.065 P = 0.302 | χ2 = 2.174 P = 0.140 |
PET/CECT vs CECT | χ2 = 0.000 P = 1.000 | χ2 = 0.000 P = 1.000 | χ2 = 0.000 P = 1.000 | χ2 = 0.000 P = 1.000 | χ2 = 0.000 P = 1.000 | χ2 = 3.640 P = 0.056 | χ2 = 0.000 P = 1.000 | χ2 = 0.057 P = 0.811 | χ2 = 2.024 P = 0.155 | χ2 = 2.763 P = 0.096 | χ2 = 5.885 P = 0.015 | χ2 = 1.015 P = 0.314 | χ2 = 0.611 P = 0.434 | χ2 = 3.880 P = 0.049 | χ2 = 3.053 P = 0.081 |
- Citation: Zhang J, Zuo CJ, Jia NY, Wang JH, Hu SP, Yu ZF, Zheng Y, Zhang AY, Feng XY. Cross-modality PET/CT and contrast-enhanced CT imaging for pancreatic cancer. World J Gastroenterol 2015; 21(10): 2988-2996
- URL: https://www.wjgnet.com/1007-9327/full/v21/i10/2988.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i10.2988